Therefore, in this study we confirmed the hypothesis that irisin levels are lower in FHA patients than in controls as a defensive mechanism to restrict brown adipose tissue (BAT) conversion [17]. The gene discussed is FNDC5; the disease is hypoalphalipoproteinemia, primary, 1.